SIMON, CHRISTOPHER (President & CEO) received a stock award from HAEMONETICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/20/2025ACC: 0001127602-25-015052
DirectorOfficer· President & CEO
Since Jul 2018
+67.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
67.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.41K
Price / share
—
Trade value
—
% of position
6.8%
5/16/2025
313.71K→335.11K
Total
Net shares
+21.41K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2025 | A · Award | +21.41K | — | — | 6.8% | 313.71K | 335.11K |
| Total | +21.41K | $0.00 | ||||||
Derivative Transactions1
Non-qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
46.34K shares
Shares
+46.34K
Strike price
70.31
Held after
46.34K
Exercisable
—
5/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) Direct | Common Stock46.34K shares | 5/16/2025 | A · Award | +46.34K | 70.31 | — | 46.34K |